Detailed Information

Cited 17 time in webofscience Cited 15 time in scopus
Metadata Downloads

The management and prognosis of patients with hepatocellular carcinoma: what has changed in 20 years?

Authors
Yim, Sun YoungSeo, Yeon SeokJung, Chang HoKim, Tae HyungLee, Jae MinKim, Eun SunKeum, BoraJong, Young KulAn, HyungginKim, Ji HoonYim, Hyung JoonKim, Dong SikJeen, Yoon TaeYeon, Jong EunLee, Hong SikChun, Hoon JaiByun, Kwan SooUm, Soon HoKim, Chang DuckRyu, Ho Sang
Issue Date
Mar-2016
Publisher
Blackwell Publishing Inc.
Keywords
hepatitis B virus; hepatocellular carcinoma; radiofrequency ablation
Citation
Liver International, v.36, no.3, pp.445 - 453
Indexed
SCIE
SCOPUS
Journal Title
Liver International
Volume
36
Number
3
Start Page
445
End Page
453
URI
https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/6685
DOI
10.1111/liv.12960
ISSN
1478-3223
Abstract
Background & aims There has been remarkable progress in the management of hepatocellular carcinoma (HCC) during the last several decades, but its effect on the prognosis of HCC patient needs clarification. We analysed the changes that affected prognosis of HCC patients diagnosed over two different eras. Methods A retrospective study of 1318 patients diagnosed with HCC from 1986 to 2012 was conducted. Analysis was done according to two cohorts, cohort 1 (patients diagnosed with HCC from 1986 to 1992) and cohort 2 (patients diagnosed from 2006 to 2012). Results Hepatitis B virus was the most common cause of liver disease for both cohorts (66.2% and 66.0%). The proportion of patients with Barcelona Clinic Liver Cancer stage 0/A was significantly lower in cohort 1 than in cohort 2 (14.4% vs. 39.5%, P < 0.001). The proportions of patients diagnosed during surveillance and general health check-up were significantly higher in cohort 2 than in cohort 1 (28.6% vs. 10.6% and 26.3% vs. 7.9%, respectively) while those diagnosed during symptomatic evaluation was significantly higher in cohort 1 than in cohort 2 (45.1 vs. 81.4%, P < 0.001). Surgical resection rate was similar between the two cohorts (26.1% vs 26%) while the transcatheter arterial chemoembolization rate which was the highest in cohort 1 (40.6%) was overtaken by radiofrequency ablation in cohort 2 (55%) at BCLC stage 0/A. Median survival duration in cohort 2 was significantly longer than cohort 1 (65.0 vs. 7.9 months, P < 0.001). Conclusions Implementation of national cancer surveillance and the advancement of treatment modalities have likely led to early detection of HCC and improvements in prognosis over the last 20 years.
Files in This Item
There are no files associated with this item.
Appears in
Collections
2. Clinical Science > Department of Internal Medicine > 1. Journal Articles
2. Clinical Science > Department of Hepato-Biliary-Pancreatic Surgery > 1. Journal Articles
1. Basic Science > Department of Biostatistics > 1. Journal Articles
2. Clinical Science > Department of Gastroenterology and Hepatology > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Kim, Dong-Sik photo

Kim, Dong-Sik
Anam Hospital (Department of Hepato-Biliary-Pancreatic Surgery, Anam Hospital)
Read more

Altmetrics

Total Views & Downloads

BROWSE